EQIP White Paper

EQIP initiative – a standardized approach to gathering and sharing key technical and digital compatibility information across the pharmaceutical and vendor landscape. This white paper outlines the current state of industry practices, the problems this initiative addresses, and the value it brings to both the pharmaceutical industry and its vendors.

This initiative was developed by the Steering Committee of the Future Labs Evolution Community, a cross-company collaboration fostered by the Pistoia Alliance and composed of representatives from nine leading pharmaceutical organizations: GSK, MSD, Merck Healthcare KGaA, CSL, Vertex, Takeda, Johnson & Johnson, Novartis, and Novo Nordisk.